NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDRuxolitinib Jakavi® Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Non Formulary items found
Status Description Section
DNPRuxolitinib Opzelura®
(15mg/g cream (for vitiligo)) 		Skin, Drugs affecting the immune response, 13.05.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Ruxolitinib Ruxolitinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA1088: Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over (NOT RECOMMENDED)
NICE TA386: Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis
NICE TA921: Ruxolitinib for treating polycythaemia vera